Vir Biotechnology to Participate in the 21st Annual Needham Healthcare Conference

SAN FRANCISCO, April 04, 2022 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the Company will participate in a fireside chat at the 21st Annual Needham Healthcare Conference on Monday, April 11, at 11:00 a.m. ET.

The conference will be held virtually. A live webcast of the panel discussion can be accessed under Events & Presentations in the Investors section of the Vir website at www.vir.bio and will be archived there for 30 days.

About Vir BiotechnologyVir Biotechnology is a commercial-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. Vir has assembled four technology platforms that are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. Its current development pipeline consists of product candidates targeting COVID-19, hepatitis B virus, influenza A and human immunodeficiency virus. Vir routinely posts information that may be important to investors on its website.

Contacts:

Investors
Heather Rowe Armstrong
VP, Investor Relations
[email protected]
+1-415-915-4228

Media
Carly Scaduto
Senior Director, Media Relations
[email protected]
+1314-368-5189

You May Also Be Interested In

• Zenbody RX Launches Telehealth Platform Built Around Personalized, Clinician-Guided GLP-1 Care
• Crypto News: Apeing’s Meme Coin Presale Gains Steam With 85% APY as Dogecoin and Pepe Command Attention
• Aster Guardians Global Nursing Award 2026 Names Agimol Pradeep From United Kingdom Winner of USD 250,000 Prize